title: Intranasal flunisolide treatment in children with adenoidal hypertrophy.
abstract: Adenoidal hypertrophy (AH) represents one of the most frequent indications for surgery in children and it has been proposed that treatment with intranasal corticosteroids can decrease the size of AH. Therefore, the aim of the study is to evaluate the effect of the use of intranasal flunisolide among children affected by AH. 178 children with AH were evaluated in this randomised and controlled study. Inclusion criteria for the study required that each patient had to have a III or IV degree of AH on the initial endoscopic examination. Children were treated with intranasal flunisolide or isotonic saline solution for 8 weeks. After treatment, endoscopy was performed to re-evaluate AH degree. Flunisolide treatment was associated with significant (p less than 0.04) reduction of AH degree. There was moreover a consistent reduction of children (46 out of 58) proposed to adenoidectomy. No clinically important adverse events were reported. In conclusion, this preliminary study demonstrates that an 8-week treatment with intranasal flunisolide is significantly associated with reduction of AH, thus preventing the recurrence to adenoidectomy, and is safe.
authors.affiliation: Department of Internal Medicine, Azienda Ospedaliera Universitaria San Martino, Genoa, Italy. gio.cip@libero.it
authors.forename: G
authors.initials: G
authors.lastname: Ciprandi
authors.forename: A
authors.initials: A
authors.lastname: Varricchio
authors.forename: M
authors.initials: M
authors.lastname: Capasso
authors.forename: A M
authors.initials: AM
authors.lastname: Varricchio
authors.forename: A
authors.initials: A
authors.lastname: De Lucia
authors.forename: E
authors.initials: E
authors.lastname: Ascione
authors.forename: F
authors.initials: F
authors.lastname: Avvisati
authors.forename: C
authors.initials: C
authors.lastname: Capristo
authors.forename: G L
authors.initials: GL
authors.lastname: Marseglia
authors.forename: U
authors.initials: U
authors.lastname: Barillari
mesh_terms: D000233:Adenoidectomy; D000234:Adenoids / Q000473:pathology*; D000281:Administration, Intranasal; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005446:Fluocinolone Acetonide / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000150:complications; D006984:Hypertrophy / Q000188:drug therapy / Q000473:pathology; D007828:Laryngoscopy; D008297:Male; D016037:Single-Blind Method; D012882:Skin Tests
chemical_list: D000893:Anti-Inflammatory Agents; D005446:Fluocinolone Acetonide; C007734:flunisolide